Doctors in the United Kingdom said they achieved a medical breakthrough by successfully treating Huntington's disease for the first time, offering what researchers are calling real hope for patients facing this devastating condition.

The experimental treatment slowed the disease's progression by 75% in patients through a type of gene therapy administered during brain surgery, according to the company behind the treatment, uniQure.

This represents the first successful treatment for Huntington's disease, which typically appears in people between the ages of 30 and 40 and is usually fatal.

RELATED STORY | What medical experts say pregnant women need to know about Tylenol, leucovorin and autism

Huntington's disease is a rare genetic condition that kills brain cells and presents as a com

See Full Page